Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: A randomized, placebo-controlled, double-blind study in healthy volunteers

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 4, 2004, Pages 303-309

  Köhler, Stephan ^a,b   Funk, Petra ^a   Kieser, Meinhard ^a  

^a Clinical Research Department   (Germany)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

Bleeding time; Coagulation; Equivalence; Ginkgo biloba special extract EGb 761; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; COLLAGEN; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; PLACEBO; RISTOCETIN; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; CELL ACTIVITY; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MONITORING; DRUG RESPONSE; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; INHIBITION KINETICS; LABORATORY; MALE; MEDICAL ASSESSMENT; NORMAL HUMAN; OUTCOMES RESEARCH; PARAMETER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD PLATELETS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; GINKGO BILOBA; HEMORRHAGE; HUMANS; MALE; PLACEBOS; PLANT EXTRACTS; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; TREATMENT OUTCOME;

EID: 2942525892     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200406000-00003     Document Type: Article

References (38)

1. Kanowski S, Hermann WM, Stephan K, Wierich W, Hörr R. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 1996; 29:47-56.
2. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997; 278:1327-1332.
3. Blume J, Kieser M, Hölscher U. Ginkgo-Spezialextrakt EGb 761 bei peripherer arterieller Verschlußkrankheit. Eine randomisierte, plazebokontrollierte Doppelblindstudie bei Patienten mit pAVK im Stadium IIb nach Fontaine. Fortschr Med 1998; 116(Originalien 4):137-143.
4. Peters H, Kieser M, Hölscher U. Demonstration of the efficacy of Ginkgo biloba special extract EGb 761 on intermittent claudication - a placebo-controlled, double-blind multicenter trial. VASA 1998; 27:106-110.
5. Morgenstern C, Biermann E. Ginkgo-Spezialextrakt EGb 761 in der Behandlung des Tinnitus aurium. Fortschr Med 1997; 115(originalien 4):7-11.
6. Wettstein A. Cholinesterase inhibitors and Ginkgo extracts - are they comparable in the treatment of dementia? Phytomedicine 2000; 6:393-401.
7. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998; 55:1409-1415.
8. DeFeudis FV. Ginkgo Biloba Extract (EGb 761). From Chemistry to the Clinic. Wiesbaden: Ullstein Medical; 1998.
9. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46:1775-1776 [see also Odawara M, Tamaoka A, Yamashita K. Letter to the editor, Neurology 1997; 48:789 and Lewis S, Rowin J. Reply from the authors. Neurology 1997; 48:789-790].
10. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46:1775-1776 [see also Odawara M, Tamaoka A, Yamashita K. Letter to the editor, Neurology 1997; 48:789 and Lewis S, Rowin J. Reply from the authors. Neurology 1997; 48:789-790].
11. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46:1775-1776 [see also Odawara M, Tamaoka A, Yamashita K. Letter to the editor, Neurology 1997; 48:789 and Lewis S, Rowin J. Reply from the authors. Neurology 1997; 48:789-790].
12. Gilbert GJ. Ginkgo biloba [Letter]. Neurology 1997; 48:1137 [see also Lewis SL, Rowin J. Reply from the authors. Neurology 1997; 48:1137].
13. Gilbert GJ. Ginkgo biloba [Letter]. Neurology 1997; 48:1137 [see also Lewis SL, Rowin J. Reply from the authors. Neurology 1997; 48:1137].
14. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract [Letter]. N Engl J Med 1997; 336:1108.
15. Matthews MK. Association of Ginkgo biloba with intracerebral hemorrhage [Letter]. Neurology 1998; 50:1933 [see also Lewis SL, Rowin J. Reply from the authors. Neurology 1998; 50:1933-1934].
16. Matthews MK. Association of Ginkgo biloba with intracerebral hemorrhage [Letter]. Neurology 1998; 50:1933 [see also Lewis SL, Rowin J. Reply from the authors. Neurology 1998; 50:1933-1934].
17. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba [Letter]. Lancet 1998; 352:36 [see also Skogh M. Extracts of Ginkgo biloba and bleeding or haemorrhage [Letter]. Lancet 1998; 352:1145-1146 and Vale S. Author's reply. Lancet 1998; 352:1146].
18. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba [Letter]. Lancet 1998; 352:36 [see also Skogh M. Extracts of Ginkgo biloba and bleeding or haemorrhage [Letter]. Lancet 1998; 352:1145-1146 and Vale S. Author's reply. Lancet 1998; 352:1146].
19. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba [Letter]. Lancet 1998; 352:36 [see also Skogh M. Extracts of Ginkgo biloba and bleeding or haemorrhage [Letter]. Lancet 1998; 352:1145-1146 and Vale S. Author's reply. Lancet 1998; 352:1146].
20. Benjamin J, Muir T, Briggs K, Pentland B. A case of cerebral haemorrhage - can Ginkgo biloba be implicated? Postgrade Med J 2001; 77:112-113.
21. DeFeudis FV. A brief history of EGb 761 and its therapeutic uses. Pharmacopsychiatry 2003; 36(suppl 1):S2-S7.
22. Guinot P, Caffrey E, Lambe R, Darragh A. Tanakan inhibits platelet-activating-factor-induced platelet aggregation in healthy male volunteers. Haemostasis 1989; 18:219-223.
23. Eckert A, Keil U, Kressmann S, Schindowski K, Leutner S, Leutz S, Müller WE. Effects of EGb 761 Ginkgo biloba Extract on mitochondrial function and oxidative stress. Pharmacopsychiatry 2003; 36(suppl 1): S15-S23.
24. Rimbach G, Wolffram S, Watanabe C, Packer L, Gohil K. Effect of Ginkgo biloba on differential gene expression. Pharmacopsychiatry 2003; 36(suppl 1):S95-S99.
25. Wolf HRD. Effect of Ginkgo biloba special extract EGb 761 and acetylsalicylic acid on coagulation: a randomized, double-blind, double-dummy crossover study in healthy subjects. (In preparation, 2004)
26. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17:237-246.
27. Ivy AC, Shapiro PF, Melnuck P. The bleeding tendency in jaundice. Sug Gynecol Obstet 1935; 60:781-784.
28. Ivy AC, Nelson D, Bucher G. The standardization of certain factors in the cutaneous 'venostasis' bleeding time technique. J Lab Clin Med 1941; 26:1812-1822.
29. Fieller E. Some problems in interval estimation. J Roy Stat Soc, Ser B 1954; 16:175-185.
30. Steinijans VW, Hauschke D, Schall R. International harmonization of regulatory requirements for average bioequivalence and current issues in individual bioequivalence. Drug Inf J 1995; 29:1055-1062.
31. Bal Dit Sollier C, Caplain H, Drouet L. No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haemost 2003; 25:251-253.
32. Kurachi K, Kurachi S. Genetic mechanisms of age regulation of blood coagulation. Arterioscler Thromb Vasc Biol 2000; 20:902-906.
33. Sagripanti A, Carpi A. Natural anticoagulants, aging, and thromboembolism. Exp Gerontol 1998; 33:891-896.
34. Dodds WJ, Moynihan AC, Benson RE, Hall CA. The value of age- and sex-matched controls for coagulation studies. Br J Haematol 1975; 29:305-317.
35. European Agency for the Evaluation of Medical Products. Note for guidance on choice of control group in clinical trials (CPMP/ICH/364/96). London: ICH Topic E 10; 2000.
36. Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets. J Clin Invest 1975; 56:624-632.
37. Büttner T, Ruhmann S, Przuntek H. Ginkgo: Radikalfänger und PAF-Antagonist. Therapiewoche 1994; 44:1394-1396.
38. Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated out-patients. A randomised, double blind, placebo-crossover trial. Thromb Haemost 2002; 87:1075-1076.